Literature DB >> 18186037

The hospital costs of care for stroke in nine European countries.

David Epstein1, Anne Mason, Andrea Manca.   

Abstract

Stroke is a major cause of mortality and morbidity, but the reasons for differences in costs of care within and between countries are not well understood. The HealthBASKET project used a vignette methodology to compare the mean costs and prices of hospital care across providers in nine European Union countries. Data on resource use, unit costs and prices of care for female stroke patients without co-morbidity were collected from a sample of 50 hospitals. Mean costs for each provider were analysed using multiple regression. Sensitivity analysis explored the effects on cost of using official exchange rates, purchasing power parity (PPP) and proportion of national income per capita. The mean cost of a hospital episode per patient for stroke at PPP was 3813 euros (standard error 227) with an additional day in hospital typically associated with 6.9% (95% CI: 4-9%) higher costs and thrombolysis associated with 41% higher costs (10-73%). After adjusting for explanatory factors, about 76% of the variation in cost could be attributed to between-country differences, and the extent of this variation was sensitive to the method of currency conversion. There was considerable variation in the care pathways within and between countries, including differences in the availability of stroke units and access to rehabilitative services, but only the length of stay and use of thrombolytic therapy were significantly associated with higher cost. The vignette methodology appears feasible, but further research needs to consider access to healthcare over a longer follow up and to include both costs and outcomes. Copyright 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18186037     DOI: 10.1002/hec.1329

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  8 in total

1.  What can we learn from international comparisons of costs by DRG?

Authors:  M Pirson; L Schenker; D Martins; Duong Dung; J J Chalé; P Leclercq
Journal:  Eur J Health Econ       Date:  2012-01-12

2.  Resource use and costs of treating acute cough/lower respiratory tract infections in 13 European countries: results and challenges.

Authors:  Raymond Oppong; Joanna Coast; Kerry Hood; Jacqui Nuttall; Richard D Smith; Christopher C Butler
Journal:  Eur J Health Econ       Date:  2010-04-03

3.  From the stroke unit to the stroke competence center: corresponding beneficial clinical and financial effects.

Authors:  A Chatzikonstantinou; A Förster; M G Hennerici; H Bäzner
Journal:  J Neurol       Date:  2011-04-06       Impact factor: 4.849

4.  Development of an Exoskeleton Platform of the Finger for Objective Patient Monitoring in Rehabilitation.

Authors:  Nikolas Jakob Wilhelm; Sami Haddadin; Jan Josef Lang; Carina Micheler; Florian Hinterwimmer; Anselm Reiners; Rainer Burgkart; Claudio Glowalla
Journal:  Sensors (Basel)       Date:  2022-06-25       Impact factor: 3.847

5.  Costs structure of the inpatient ischemic stroke treatment using an exact costing method.

Authors:  Anne Puumalainen; Outi Elonheimo; Mats Brommels
Journal:  Heliyon       Date:  2020-06-23

6.  Cost Assessment of Inpatient Care Episodes of Stroke in Romania.

Authors:  László Lorenzovici; Andrea Székely; Marcell Csanádi; Péter Gaál
Journal:  Front Public Health       Date:  2020-12-04

7.  Cost-effectiveness of a photopethysmographic procedure for screening for atrial fibrillation in 6 European countries.

Authors:  Steffen Wahler; Ralf Birkemeyer; Dimitrios Alexopoulos; Zbigniew Siudak; Alfred Müller; Johann-Matthias von der Schulenburg
Journal:  Health Econ Rev       Date:  2022-02-26

8.  The social and economic burden of stroke survivors in Italy: a prospective, incidence-based, multi-centre cost of illness study.

Authors:  Giovanni Fattore; Aleksandra Torbica; Alessandra Susi; Aguzzi Giovanni; Giancarlo Benelli; Marianna Gozzo; Vito Toso
Journal:  BMC Neurol       Date:  2012-11-14       Impact factor: 2.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.